Delve into the complex landscape of non-Hodgkin lymphoma research, where a cure is pursued amidst a backdrop of over 100 subtypes of this disease.

In this episode, Dr. Kieron Dunleavy, of MedStar Georgetown University Hospital, breaks down the differences in treatments, prognosis and goals for both slow-growing and aggressive subtypes of non-Hodgkin lymphoma. Discover the remarkable momentum of scientific progress that increased the understanding and management of lymphoma, igniting a renewed sense of hope for patients and their loved ones.

Mentioned on this episode: 

• Non-Hodgkin lymphoma
  
  
• Chronic lymphocytic leukemia
  
  
• POLARIX study
  
  
• Stem Cell Transplantion
  
  
• CAR T-cell Therapy
  
  
• ZUMA-7 Study
  
  
• TRANSFORM Study
  
  
• Graft-vs-host Disease (GVHD)
  
  
• Minimal/Measurable Residual Disease (MRD)
  
  
• Clinical Trial Support Center
  

Additional LLS Support Resources: 

• Information Specialists 
  
  
• Free telephone/web patient programs 
  
  
• Free booklets 
  
  
• Financial support
  
  
• Caregiver support 
  
  
• Young Adult Resources
  
  
• Survivorship Workbook
  
  
• Online chats 
  
  
• LLS Community 
  
  
• Support groups 
  
  
• Patti Robinson Kaufmann First Connection Program 
  
  
• Free Nutrition Consultations
  

Support for this episode provided by: Eli Lilly and Company and Genentech, Inc. & Biogen.

The post Accelerating Hope for Aggressive Non-Hodgkin Lymphoma appeared first on The Bloodline with LLS.